A Central India Perspective on Leprosy and Its Association with Diabetes Mellitus

CC BY-NC-ND 4.0 · Journal of Social Health and Diabetes 2019; 07(01): 037-038
DOI: 10.1055/s-0039-1692334

Letter to the Editor

Novo Nordisk Education Foundation

Authors

Amritava Ghosh

¹Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India

References
1 National leprosy eradication programme. NLEP Annual Report 2016–2017. Available at: http://www.nlep.nic.in/pdf/Annual%20report_%202016-17.pdf Accessed February 20, 2019
2 Rao PN, Suneetha S. Current situation of leprosy in India and its future implications. Indian Dermatol Online J 2018; 9 (02) 83-89
3 Saraya MA, Al-Fadhli MA, Qasem JA. Diabetic status of patients with leprosy in Kuwait. J Infect Public Health 2012; 5 (05) 360-365
4 Nigam P, Dayal SG, Srivastava P. et al. Diabetic status in leprosy. Hansenol Int 1979; 4 (01) 7-14
5 Lockwood DNJ. Chronic aspects of leprosy-neglected but important. Trans R Soc Trop Med Hyg 2019; 00: 1-5
6 Rawson TM, Anjum V. Leprosy interpreted as diabetes related complications. Indian J Lepr 2014; 86 (02) 65-67
7 van Crevel R, van de Vijver S, Moore DAJ. The global diabetes epidemic: what does it mean for infectious diseases in tropical countries?. Lancet Diabetes Endocrinol 2017; 5 (06) 457-468
8 Gardiner BJ, Machado PRL, Ooi WW. Comorbidities in patients with Hansen's disease. In: Scollard DM, Gillis TP. eds. The International Textbook of Leprosy. Available at: https://internationaltextbookofleprosy.org/chapter/co-morbidities-patients-hansens-disease Accessed February 19, 2019